NCT06151223
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Clinical trial condition
PDAC
Explore clinical trials studying PDAC. Study availability and eligibility vary by location and protocol.
20 public trials
14 recruiting studies
PDAC trial results
NCT07441174
- Conditions
- PDAC, Solid Tumor Cancer
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
NCT07259590
- Conditions
- Advanced Solid Tumors Cancer, CRC (Colorectal Cancer), Colonic Diseases, +11 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT06515587
- Conditions
- PDAC
- Locations
-
- Shanghai General Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
The Canopy Cancer Collective Clinical Registry Protocol
NCT07605702
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +18 more
- Locations
-
- UC San Diego Health San Diego, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
Not Yet Recruiting
A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors
NCT07198321
- Conditions
- CRC (Colorectal Cancer), Cancer, Colonic Diseases, +12 more
- Locations
-
- Sun-Yat sen university cancer center Guangzhou, Guangdong, China
Not Yet Recruiting
Mesopancreas Study in Pancreatic Cancer
NCT05895214
- Conditions
- Local Recurrent Tumor, Margin, Resection, Margins of Excision, +5 more
- Locations
-
- University Hospital Duesseldorf, Heinrich Heine University Düsseldorf, Germany
Active, Not Recruiting
ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
NCT05355298
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
- Locations
-
- GenesisCare St Leonards, New South Wales, Australia
- Calvary Mater Newcastle Waratah, New South Wales, Australia
- Westmead Hospital Westmead, New South Wales, Australia
- Gallipolli Medical Research Foundation Greenslopes, Queensland, Australia
Active, Not Recruiting
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
NCT06625320
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Mayo Clinic Cancer Center - Phoenix Phoenix, Arizona, United States
- City of Hope-Duarte Duarte, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
Active, Not Recruiting
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
NCT05642962
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +18 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States